Oncologie Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA (Pembrolizumab) Read more
Boehringer and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies Read more
Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials Read more
Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis in Japan Read more